Company Financials

CONMED Corporation Financials

United States dollar

business CONMED Corporation Company Profile

Main Stock Listing

NYSE: CNMD

Market Capitalization $2.12 Billion as of Jan. 1, 2025

Market Cap History

Valuations Metrics as of Jan. 25, 2025

Trailing PE 16.23
Forward PE 14.15
Price to Sales TTM $1.64
Price to Book MRQ $2.27
Enterprise to Revenue 2.34
Enterprise to EBITDA 13.86

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends 2023-12-31
Most Recent Quarter 2024-09-30
Profit Margin 10.23%
Operating Margin 12.22%
Return on Assets TTM 3.98%
Return on Equity TTM 15.24%

Income Statement

Revenue TTM $1,288,115,968
Revenue per Share TTM $41.82
Quarterly Revenue Growth 4.00%
Gross Profit TTM $718,963,008
EBITDA $269,867,000
Net Income to Common TTM $131,739,000
Diluted EPS TTM $4.22
Quarterly Earnings Growth YoY 209.30%

Balance Sheet

Total Cash MRQ $38,467,000
Total Cash per Share MRQ $1.25
Total Debt MRQ $
Total Debt to Equity MRQ 100.85
Current Ratio MRQ 2.27
Book Value per Share MRQ $30.21

Cash Flow

Operating Cash Flow TTM $180,024,992
Levered Free Cash Flow TTM $126,049,000

CNMD Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding 30,890,900
Float Shares 30,610,364
Avg 10 Volume 438,360
Avg 30 Volume None
Shares Short 2,375,514
Short Ratio 5.99
Short % of Shares 10.66%
% Held by Insiders 0.58%
% Held by Institutions 114.62%

Stock Price Summary

Beta 1.46
Fifty Two Week Low $61.05
Fifty Two Week High $97.08
Fifty Two Week Change -38.10%
Day 50 MA $71.36
Day 200 MA $70.71

Dividends and Splits

Forward Annual Dividend Rate $0.80
Forward Annual Dividend Yield 1.16%
Trailing Annual Dividend Rate $0.80
Trailing Annual Dividend Yield 1.16%
Payout Ratio 18.96%
Dividend Date 2025-01-03
Ex Dividend Date 2024-12-20
Last Split Factor
Last Split Date 2001-09-10